Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation

作者: Malgorzata Milewska , David Romano , Ana Herrero , Maria Luisa Guerriero , Marc Birtwistle

DOI: 10.1371/JOURNAL.PONE.0129859

关键词:

摘要: BRAF functions in the RAS-extracellular signal-regulated kinase (ERK) signaling cascade. Activation of this pathway is necessary to mediate transforming potential oncogenic BRAF, however, it may also cause a negative feedback that inhibits epidermal growth factor receptor (EGFR). Mitogen-inducible gene-6 (MIG-6) potent inhibitor EGFR and has been demonstrated function as tumor suppressor. As MIG-6 can be induced via RAS-ERK signaling, we investigated its involvement regulatory loop. Focus formation assays were performed significantly reduces malignant transformation by BRAF. Although genetic interaction was mirrored physical between did not observe direct regulation activity MIG-6. Interestingly, selective chemical suppressed similar degree MIG-6, whereas combining these approaches had no synergistic effect. By analyzing range mutated wildtype cell line models, could show V600E causes strong upregulation which mediated at transcriptional level resulted downregulation activation. This loop operational tumors, shown analysis almost 400 patients with papillary thyroid cancer (PTC). Presence correlated increased expression on one hand, inactivation PI3K/AKT other hand. Importantly, observed more aggressive disease phenotype when coexisted low expression. Finally, methylation data revealed higher decreased Taken together, demonstrate efficiently cellular driven orchestrating circuit directed towards EGFR.

参考文章(60)
Tae Hyuk Kim, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, You Jin Lee, Kyung Won Kim, Seo Kyung Hahn, Yeo Kyu Youn, Kwang Hyun Kim, Bo Youn Cho, Do Joon Park, The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer Cancer. ,vol. 118, pp. 1764- 1773 ,(2012) , 10.1002/CNCR.26500
Ning Liu, Masaki Matsumoto, Kyoko Kitagawa, Yojiro Kotake, Sayuri Suzuki, Senji Shirasawa, Keiichi I Nakayama, Makoto Nakanishi, Hiroyuki Niida, Masatoshi Kitagawa, Chk1 phosphorylates the tumour suppressor Mig‐6, regulating the activation of EGF signalling The EMBO Journal. ,vol. 31, pp. 2365- 2377 ,(2012) , 10.1038/EMBOJ.2012.88
Maria Sibilia, Alexander Fleischmann, Axel Behrens, Laura Stingl, Joseph Carroll, Fiona M. Watt, Joseph Schlessinger, Erwin F. Wagner, The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development Cell. ,vol. 102, pp. 211- 220 ,(2000) , 10.1016/S0092-8674(00)00026-X
Monia Fiorini, Costanza Ballarò, Gianluca Sala, Germana Falcone, Stefano Alemà, Oreste Segatto, Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control. Oncogene. ,vol. 21, pp. 6530- 6539 ,(2002) , 10.1038/SJ.ONC.1205823
A. Zebisch, J. Troppmair, Back to the roots: the remarkable RAF oncogene story. Cellular and Molecular Life Sciences. ,vol. 63, pp. 1314- 1330 ,(2006) , 10.1007/S00018-006-6005-Y
Gideon Bollag, James Tsai, Jiazhong Zhang, Chao Zhang, Prabha Ibrahim, Keith Nolop, Peter Hirth, Vemurafenib: the first drug approved for BRAF -mutant cancer Nature Reviews Drug Discovery. ,vol. 11, pp. 873- 886 ,(2012) , 10.1038/NRD3847
Markus Reschke, Ingvar Ferby, Ewa Stepniak, Nina Seitzer, David Horst, Erwin F Wagner, Axel Ullrich, None, Mitogen‐inducible gene‐6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma Hepatology. ,vol. 51, pp. 1383- 1390 ,(2010) , 10.1002/HEP.23428
A Zebisch, A Wölfler, I Fried, O Wolf, K Lind, C Bodner, M Haller, A Drasche, D Pirkebner, D Matallanas, O Rath, K Blyth, R Delwel, E Taskesen, F Quehenberger, W Kolch, J Troppmair, H Sill, Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia Leukemia. ,vol. 26, pp. 1842- 1849 ,(2012) , 10.1038/LEU.2012.61
Chong Sun, Liqin Wang, Sidong Huang, Guus J. J. E. Heynen, Anirudh Prahallad, Caroline Robert, John Haanen, Christian Blank, Jelle Wesseling, Stefan M. Willems, Davide Zecchin, Sebastijan Hobor, Prashanth K. Bajpe, Cor Lieftink, Christina Mateus, Stephan Vagner, Wipawadee Grernrum, Ingrid Hofland, Andreas Schlicker, Lodewyk F. A. Wessels, Roderick L. Beijersbergen, Alberto Bardelli, Federica Di Nicolantonio, Alexander M. M. Eggermont, Rene Bernards, Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma Nature. ,vol. 508, pp. 118- 122 ,(2014) , 10.1038/NATURE13121